Fisher & Paykel Healthcare Introduces New Premium Flow Generators and Masks

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it has further expanded its CPAP flow generator and mask offering for the treatment of obstructive sleep apnea.

The company will be introducing a new premium CPAP range and two new masks at the Medtrade
Exhibition in Atlanta, Georgia next week.

The new SleepStyle 240 CPAP flow generators are able to collect data during treatment onto a removable  USB  SmartStick  flash  memory  device  which  may  be  conveniently  reviewed  by  the patient’s physician without the need for any special card reading hardware.

“The ability to provide efficacy reporting and removable media opens up a new product category for Fisher & Paykel Healthcare. The SleepStyle 240 range will broaden our premium flow generator device offering alongside our SleepStyle Auto flow generator, which incorporates our unique SensAwake technology,” commented Michael Daniell, Fisher & Paykel Healthcare’s Chief Executive Officer.

The innovative design of the Zest nasal mask combines a new Easy-Clip silicone seal with previously proven Fisher & Paykel Healthcare technology. The Zest is small, quiet and is designed to fit most patients straight out of the box. The new Forma full face mask offers enhanced comfort with a greater range of movement due to its new FlexiFoam cushion. The cushion is soft and light and features advanced active contouring that conforms naturally to the patient’s face.

“The new masks include technologies  that will help to improve comfort, seal and ease of use for CPAP patients while still incorporating a number of our already proven benefits such as FlexiFit,” said Mr Daniell.

About Fisher & Paykel Healthcare
Fisher  & Paykel  Healthcare  is a leading  designer,  manufacturer  and  marketer  of products  and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea.  The company’s  products  are sold in over 110 countries  worldwide.   For more information  about  the company visit

Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.